Skip to main content

Med Fusion HemeSEQ Profiles

Med Fusion has launched an expansion of its oncology testing services to include HemeSEQ portfolio of next-generation sequencing profiles. The profiles cover four hematologic neoplasms: Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Diffuse Large B-Cell Lymphoma, and Myeloproliferative Neoplasms. These profiles expand the company's hematologic testing menu to nearly 100 tests and incorporate next-generation sequencing technology. Customer tests results are matched with relevant clinical trials and therapy options based on the specific genomic signature of the patient's disease, the company said. The final report is easy to read and delivers oncologists a powerful tool to access diagnosis and prognosis of patients living with hematologic disease.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.